ARTICLE | Company News
Teva, AstraZeneca autoimmune news
May 24, 2010 7:00 AM UTC
AstraZeneca granted Teva a license to market Teva's generic version of AstraZeneca's Entocort EC budesonide on Feb. 15, 2012, or earlier in certain circumstances to treat Crohn's disease. The license...